Back to User profile » Professor Maurizio Pompili
Papers published by Professor Maurizio Pompili:
Efficacy and Safety of Paliperidone Palmitate 6-Month versus Paliperidone Palmitate 3-Month Long-Acting Injectable in European Patients with Schizophrenia: A Post Hoc Analysis of a Global Phase-3 Double-Blind Randomized Non-Inferiority Study
Giron‐Hernandez C, Han JH, Alberio R, Singh A, García-Portilla MP, Pompili M, Knight RK, Richarz U, Gopal S, Antunes J
Neuropsychiatric Disease and Treatment 2023, 19:895-906
Published Date: 13 April 2023
Neuropsychiatric disturbances in atypical parkinsonian disorders
Belvisi D, Berardelli I, Suppa A, Fabbrini A, Pasquini M, Pompili M, Fabbrini G
Neuropsychiatric Disease and Treatment 2018, 14:2643-2656
Published Date: 9 October 2018
Cognitive behavioral group therapy versus psychoeducational intervention in Parkinson’s disease
Berardelli I, Bloise MC, Bologna M, Conte A, Pompili M, Lamis DA, Pasquini M, Fabbrini G
Neuropsychiatric Disease and Treatment 2018, 14:399-405
Published Date: 26 January 2018
Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice
Dell’Osso B, Albert U, Atti AR, Carmassi C, Carrà G, Cosci F, Del Vecchio V, Di Nicola M, Ferrari S, Goracci A, Iasevoli F, Luciano M, Martinotti G, Nanni MG, Nivoli A, Pinna F, Poloni N, Pompili M, Sampogna G, Tarricone I, Tosato S, Volpe U, Fiorillo A
Neuropsychiatric Disease and Treatment 2015, 11:1885-1909
Published Date: 30 July 2015
Support management in schizophrenia: a systematic review of current literature
Pompili M, Montebovi F, Forte A, Palermo M, Stefani H, Telesforo L, Campi S, Giordano G, Longo L, Lamis DA, Serafini G, Girardi P
Patient Intelligence 2012, 4:79-101
Published Date: 17 December 2012
The role of asenapine in the treatment of manic or mixed states associated with bipolar I disorder
Pompili M, Venturini P, Innamorati M , Serafini G, Telesforo L, Lester D, Tatarelli R, Girardi P
Neuropsychiatric Disease and Treatment 2011, 7:259-265
Published Date: 6 May 2011
Persistent suicide risk in clinically improved schizophrenia patients: challenge of the suicidal dimension
Amresh Shrivastava, Megan E Johnston, Nilesh Shah, et al
Neuropsychiatric Disease and Treatment 2010, 6:633-638
Published Date: 22 September 2010
Psychiatric comorbidity and suicide risk in patients with chronic migraine
Maurizio Pompili, Gianluca Serafini, Daniela Di Cosimo, et al
Neuropsychiatric Disease and Treatment 2010, 6:81-91
Published Date: 1 April 2010
Suicide risk in depression and bipolar disorder: Do impulsiveness-aggressiveness and pharmacotherapy predict suicidal intent?
Maurizio Pompili, Marco Innamorati, Michele Raja, Ilaria Falcone, Giuseppe Ducci, et al
Neuropsychiatric Disease and Treatment 2008, 4:247-255
Published Date: 8 February 2008